Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

被引:31
作者
Boucher, Yves [1 ,2 ]
Kumar, Ashwin S. [1 ,2 ,3 ]
Posada, Jessica M. [1 ,2 ,4 ]
Gjini, Evisa [5 ,6 ]
Pfaff, Kathleen [5 ]
Lipschitz, Mikel [5 ]
Lako, Ana [5 ,6 ]
Duda, Dan G. [1 ,2 ]
Rodig, Scott J. [4 ,5 ]
Hodi, F. Stephen [5 ,7 ]
Jain, Rakesh K. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[4] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02115 USA
[6] Bristol Myers Squibb, Cambridge, MA USA
[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; NORMALIZATION; CHEMOTHERAPY;
D O I
10.1038/s41698-021-00197-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A single dose of bevacizumab reduced the density of angiopoietin-2-positive vessels while improving the infiltration of CD4+ T and CD8+ T cells, and mature dendritic cells in patients with primary triple-negative breast cancer. Our findings provide a rationale for including bevacizumab during neoadjuvant treatment to enhance the efficacy of immune checkpoint blockers in this disease.
引用
收藏
页数:6
相关论文
共 17 条
[1]   QuPath: Open source software for digital pathology image analysis [J].
Bankhead, Peter ;
Loughrey, Maurice B. ;
Fernandez, Jose A. ;
Dombrowski, Yvonne ;
Mcart, Darragh G. ;
Dunne, Philip D. ;
McQuaid, Stephen ;
Gray, Ronan T. ;
Murray, Liam J. ;
Coleman, Helen G. ;
James, Jacqueline A. ;
Salto-Tellez, Manuel ;
Hamilton, Peter W. .
SCIENTIFIC REPORTS, 2017, 7
[2]   Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells [J].
Bourdely, Pierre ;
Anselmi, Giorgio ;
Vaivode, Kristine ;
Ramos, Rodrigo Nalio ;
Missolo-Koussou, Yoann ;
Hidalgo, Sofia ;
Tosselo, Jimena ;
Nunez, Nicolas ;
Richer, Wilfrid ;
Vincent-Salomon, Anne ;
Saxena, Alka ;
Wood, Kristie ;
Lladser, Alvaro ;
Piaggio, Eliane ;
Helft, Julie ;
Guermonprez, Pierre .
IMMUNITY, 2020, 53 (02) :335-+
[3]   Tumor-Infiltrating Lymphocyctes in Triple-Negative Breast Cancer Update for 2020 [J].
Brown, Lauren C. ;
Salgado, Roberto ;
Luen, Stephen J. ;
Savas, Peter ;
Loi, Sherene .
CANCER JOURNAL, 2021, 27 (01) :25-31
[4]   Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion [J].
Coffelt, Seth B. ;
Chen, Yung-Yi ;
Muthana, Munitta ;
Welford, Abigail F. ;
Tal, Andrea O. ;
Scholz, Alexander ;
Plate, Karl H. ;
Reiss, Yvonne ;
Murdoch, Craig ;
De Palma, Michele ;
Lewis, Claire E. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (07) :4183-4190
[5]  
Cortes J, 2020, LANCET, V396, P1817, DOI 10.1016/S0140-6736(20)32531-9
[6]  
Emens, JNCI-J NATL CANCER I, DOI [10.1093/jnci/djab004(2021, DOI 10.1093/JNCI/DJAB004(2021]
[7]   Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells [J].
Gabrilovich, DI ;
Chen, HL ;
Cunningham, HT ;
Meny, GM ;
Nadaf, S ;
Kavanaugh, D ;
Carbone, DP .
NATURE MEDICINE, 1996, 2 (10) :1096-1103
[8]   Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer [J].
Guo, Liang ;
Cao, Chunmei ;
Goswami, Shyamal ;
Huang, Xiaoyan ;
Ma, Linxiaoxi ;
Guo, Yicheng ;
Yang, Benlong ;
Li, Teng ;
Chi, Yayun ;
Zhang, Xiaoming ;
Wu, Jiong .
CLINICAL SCIENCE, 2020, 134 (07) :711-726
[9]   Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy [J].
Huang, Yuhui ;
Yuan, Jianping ;
Righi, Elda ;
Kamoun, Walid S. ;
Ancukiewicz, Marek ;
Nezivar, Jean ;
Santosuosso, Michael ;
Martin, John D. ;
Martin, Margaret R. ;
Vianello, Fabrizio ;
Leblanc, Pierre ;
Munn, Lance L. ;
Huang, Peigen ;
Duda, Dan G. ;
Fukumura, Dai ;
Jain, Rakesh K. ;
Poznansky, Mark C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (43) :17561-17566
[10]   Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab A Secondary Analysis of the NeoALTTO Trial [J].
Salgado, Roberto ;
Denkert, Carsten ;
Campbell, Christine ;
Savas, Peter ;
Nuciforo, Paolo ;
Aura, Claudia ;
de Azambuja, Evandro ;
Eidtmann, Holger ;
Ellis, Catherine E. ;
Baselga, Jose ;
Piccart-Gebhart, Martine J. ;
Michiels, Stefan ;
Bradbury, Ian ;
Sotiriou, Christos ;
Loi, Sherene .
JAMA ONCOLOGY, 2015, 1 (04) :448-455